Surgery Partners Stock Performance
| SGRY Stock | USD 24.21 0.18 0.74% |
On a scale of 0 to 100, Surgery Partners holds a performance score of 6. The entity has a beta of 0.74, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, Surgery Partners' returns are expected to increase less than the market. However, during the bear market, the loss of holding Surgery Partners is expected to be smaller as well. Please check Surgery Partners' downside variance, as well as the relationship between the daily balance of power and relative strength index , to make a quick decision on whether Surgery Partners' existing price patterns will revert.
Risk-Adjusted Performance
OK
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Surgery Partners are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of fairly fragile basic indicators, Surgery Partners showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (0.74) | Five Day Return 1.25 | Year To Date Return 13.72 | Ten Year Return 27.42 | All Time Return 27.42 |
1 | Insider Trading | 01/10/2025 |
2 | Surgery Partners jumps on 25.75 a share offer from Bain Capital - Seeking Alpha | 01/28/2025 |
3 | Disposition of 167 shares by Danielle Burkhalter of Surgery Partners at 25.68 subject to Rule 16b-3 | 02/04/2025 |
4 | Disposition of 26520 shares by Evans Jason Eric of Surgery Partners at 25.65 subject to Rule 16b-3 | 02/07/2025 |
5 | Harmonic Issues Weak Guidance, Joins Fluence Energy, Amkor Technology And Other Big Stocks Moving Lower In Tuesdays Pre-Market Session | 02/11/2025 |
6 | Surgery Partners Inc Q4 2024 Earnings Report Preview What To Expect | 02/28/2025 |
7 | Surgery Partners, Inc. Announces Fourth Quarter and Full Year 2024 Results Sets 2025 Guidance | 03/03/2025 |
8 | Q4 2024 Surgery Partners Inc Earnings Call Transcript | 03/04/2025 |
9 | Acquisition by Marissa Brittenham of 10084 shares of Surgery Partners at 23.8 subject to Rule 16b-3 | 03/06/2025 |
10 | Disposition of 3156 shares by Marissa Brittenham of Surgery Partners at 24.09 subject to Rule 16b-3 | 03/10/2025 |
11 | Surgery Partners Price Target Lowered to 33.00 at Macquarie - Defense World | 03/12/2025 |
12 | Acquisition by Marissa Brittenham of 2886 shares of Surgery Partners at 31.18 subject to Rule 16b-3 | 03/14/2025 |
13 | Surgery Partners Executive Makes Notable Stock Sale - TipRanks | 03/17/2025 |
| Begin Period Cash Flow | 195.9 M |
Surgery |
Surgery Partners Relative Risk vs. Return Landscape
If you would invest 2,110 in Surgery Partners on December 22, 2024 and sell it today you would earn a total of 311.00 from holding Surgery Partners or generate 14.74% return on investment over 90 days. Surgery Partners is currently generating 0.2757% in daily expected returns and assumes 3.2101% risk (volatility on return distribution) over the 90 days horizon. In different words, 28% of stocks are less volatile than Surgery, and 95% of all traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Surgery Partners Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Surgery Partners' investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Surgery Partners, and traders can use it to determine the average amount a Surgery Partners' price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0859
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | SGRY | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.21 actual daily | 28 72% of assets are more volatile |
Expected Return
| 0.28 actual daily | 5 95% of assets have higher returns |
Risk-Adjusted Return
| 0.09 actual daily | 6 94% of assets perform better |
Based on monthly moving average Surgery Partners is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Surgery Partners by adding it to a well-diversified portfolio.
Surgery Partners Fundamentals Growth
Surgery Stock prices reflect investors' perceptions of the future prospects and financial health of Surgery Partners, and Surgery Partners fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Surgery Stock performance.
| Return On Equity | 0.0036 | ||||
| Return On Asset | 0.0401 | ||||
| Profit Margin | (0.05) % | ||||
| Operating Margin | 0.20 % | ||||
| Current Valuation | 6.55 B | ||||
| Shares Outstanding | 127.61 M | ||||
| Price To Earning | 61.84 X | ||||
| Price To Book | 1.74 X | ||||
| Price To Sales | 1.00 X | ||||
| Revenue | 3.11 B | ||||
| Gross Profit | 745.6 M | ||||
| EBITDA | 501.4 M | ||||
| Net Income | 12.5 M | ||||
| Cash And Equivalents | 227.4 M | ||||
| Cash Per Share | 2.58 X | ||||
| Total Debt | 393.5 M | ||||
| Debt To Equity | 1.44 % | ||||
| Current Ratio | 1.51 X | ||||
| Book Value Per Share | 14.18 X | ||||
| Cash Flow From Operations | 300.1 M | ||||
| Earnings Per Share | (1.33) X | ||||
| Market Capitalization | 3.11 B | ||||
| Total Asset | 7.89 B | ||||
| Retained Earnings | (737.3 M) | ||||
| Working Capital | 495 M | ||||
| Current Asset | 310.96 M | ||||
| Current Liabilities | 181.29 M | ||||
About Surgery Partners Performance
Evaluating Surgery Partners' performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Surgery Partners has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Surgery Partners has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 13.62 | 16.24 | |
| Return On Tangible Assets | (0.06) | (0.06) | |
| Return On Capital Employed | 0.05 | 0.06 | |
| Return On Assets | (0.02) | (0.02) | |
| Return On Equity | (0.09) | (0.09) |
Things to note about Surgery Partners performance evaluation
Checking the ongoing alerts about Surgery Partners for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Surgery Partners help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Surgery Partners had very high historical volatility over the last 90 days | |
| Over 99.0% of the company shares are owned by institutional investors | |
| Latest headline from news.google.com: Surgery Partners Executive Makes Notable Stock Sale - TipRanks |
- Analyzing Surgery Partners' financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Surgery Partners' stock is overvalued or undervalued compared to its peers.
- Examining Surgery Partners' industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Surgery Partners' management team can have a significant impact on its success or failure. Reviewing the track record and experience of Surgery Partners' management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Surgery Partners' stock. These opinions can provide insight into Surgery Partners' potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Surgery Stock Analysis
When running Surgery Partners' price analysis, check to measure Surgery Partners' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Surgery Partners is operating at the current time. Most of Surgery Partners' value examination focuses on studying past and present price action to predict the probability of Surgery Partners' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Surgery Partners' price. Additionally, you may evaluate how the addition of Surgery Partners to your portfolios can decrease your overall portfolio volatility.